Last updated: February 26, 2024
Sponsor: Haukeland University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Acute Pain
Coronary Artery Disease
Circulation Disorders
Treatment
Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)
Clinical Study ID
NCT04774913
195282
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Ability to provide written informed consent
- Comply with the procedural and study follow-up schedule
- Planned CTO PCI in accordance with the European and American appropriateness criteria.
- CTO defined as high-risk
Exclusion
Exclusion Criteria:
- Non-high risk CTO
- Occlusion within a stent
- Flush aorto-ostial occlusion of RCA and Left Main (LMS)
- Limited arterial access precluding repeat procedure
- Baseline non invasive testing showing non-viable target vessel territory
- Contra-indication to dual antiplatelet therapy
- Pregnancy
- Prior radiation skin injury
- Lack of informed consent
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)
Phase:
Study Start date:
December 08, 2021
Estimated Completion Date:
April 30, 2027
Connect with a study center
Haukeland University Hospital
Bergen, 5021
NorwayActive - Recruiting
Golden Jubilee National Hospital
Glasgow, G814DY
United KingdomActive - Recruiting
Columbia University Medical Center/ NewYork Presbyterian Hospital
New York, New York 10032
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.